NEO

Neogenomics Inc

Jun 12 • 04:00PM ET

11.15

-0.32 -2.79 %

Healthcare • Diagnostics & Research • USA • Small • NASD

Peers: VCYT BLLN GRAL NTRA QGEN DGX LH A DHR TMO

| Held by: FBT IJR VTI IWM VB VBK SPSM VXF IWN IJT

Index	RUT	P/E	-	EPS (ttm)	-0.77	Insider Own	1.88%	Shs Outstand	129.65M	Perf Week	2.29%
Market Cap	1.45B	Forward P/E	30.59	EPS next Y	0.36	Insider Trans	-1.11%	Shs Float	127.77M	Perf Month	34.99%
Enterprise Value	1.71B	PEG	0.50	EPS next Q	0.03	Inst Own	106.75%	Short Float	6.64%	Perf Quarter	41.50%
Income	-99.21M	P/S	1.95	EPS this Y	50.00%	Inst Trans	5.44%	Short Ratio	4.48	Perf Half Y	-7.08%
Sales	745.97M	P/B	1.74	EPS next Y	102.53%	ROA	-6.73%	Short Interest	8.49M	Perf YTD	-5.19%
Book/sh	6.39	P/C	9.93	EPS next 5Y	61.23%	ROE	-11.56%	52W High	13.74 -18.85%	Perf Year	50.88%
Cash/sh	1.12	P/FCF	-	EPS past 3/5Y	10.12% -	ROIC	-8.05%	52W Low	4.72 136.23%	Perf 3Y	-31.00%
Dividend Est.	-	EV/EBITDA	467.10	Sales past 3/5Y	12.58% 10.35%	Gross Margin	40.88%	Volatility	4.37% 5.39%	Perf 5Y	-74.13%
Dividend TTM	-	EV/Sales	2.30	EPS Y/Y TTM	-26.52%	Oper. Margin	-8.42%	ATR (14)	0.56	Perf 10Y	32.74%
Dividend Ex-Date	-	Quick Ratio	4.06	Sales Y/Y TTM	10.95%	Profit Margin	-13.30%	RSI (14)	65.08	Recom	1.67
Dividend Gr. 3/5Y	- -	Current Ratio	4.42	EPS Q/Q	34.94%	SMA20	10.95%	Beta	1.77	Target Price	15.06
Payout	-	Debt/Eq	0.49	Sales Q/Q	11.09%	SMA50	22.49%	Rel Volume	0.78	Prev Close	11.47
Employees	2500	LT Debt/Eq	0.49	Earnings	Apr 28 AMC	SMA200	12.18%	Avg Volume	1.89M	Price	11.15
IPO	Nov 10, 1999	Option/Short	Yes / Yes	EPS/Sales Surpr.	72.41% 1.16%	Trades		Volume	1,480,991	Change	-2.79%

Date	Action	Analyst	Rating Change	Price Target Change
Apr-29-26	Upgrade	Leerink Partners	Market Perform → Outperform	$25
Jul-30-25	Downgrade	BTIG Research	Buy → Neutral
Jul-29-25	Downgrade	William Blair	Outperform → Mkt Perform
May-15-25	Initiated	Guggenheim	Neutral
Apr-30-25	Downgrade	Leerink Partners	Outperform → Market Perform	$9
Jan-13-25	Downgrade	The Benchmark Company	Buy → Hold
Dec-10-24	Initiated	Jefferies	Buy	$22
May-01-24	Resumed	Craig Hallum	Buy	$26
Dec-29-23	Reiterated	BTIG Research	Buy	$25 → $21
Aug-21-23	Upgrade	Stephens	Equal-Weight → Overweight	$18
May-16-23	Downgrade	Raymond James	Outperform → Mkt Perform
May-09-23	Upgrade	BTIG Research	Neutral → Buy	$25
Feb-24-23	Upgrade	The Benchmark Company	Hold → Buy	$20
Feb-01-23	Upgrade	Needham	Hold → Buy	$15
Aug-26-22	Downgrade	The Benchmark Company	Buy → Hold
Aug-22-22	Downgrade	Needham	Buy → Hold
Jun-03-22	Initiated	Piper Sandler	Overweight	$13
Mar-29-22	Downgrade	Stephens	Overweight → Equal-Weight	$34 → $16
Mar-29-22	Downgrade	BofA Securities	Buy → Neutral	$25 → $18
Jan-18-22	Resumed	Stephens	Overweight	$40

Show Previous Ratings

May-15-26 09:05AM	NeoGenomics to Participate in Upcoming Investor Conferences (Business Wire)
Apr-29-26 07:27AM	NeoGenomics Shares Jump on Earnings and Analyst Upgrades (InvestorsHub)
03:09AM	NeoGenomics Inc (NEO) Q1 2026 Earnings Call Highlights: Strong Revenue Growth and Strategic ... (GuruFocus.com)
Apr-28-26 04:58PM	NeoGenomics: Q1 Earnings Snapshot (Associated Press)
04:05PM	NeoGenomics Reports First Quarter 2026 Results (Business Wire)
12:33PM	Loading…
Apr-23-26 12:33PM	SkylineDx Presents Gene Expression Profiling for Skin Cancer Metastases (Exec Edge)
07:05AM	NeoGenomics Expands Access to Full Oncology Testing Portfolio Through Epic Aura Integration (Business Wire)
Apr-13-26 07:05AM	NeoGenomics to Present Multiple Abstracts Showcasing New Research at AACR Annual Meeting 2026 (Business Wire)
Apr-07-26 07:05AM	NeoGenomics to Report First Quarter 2026 Financial Results on April 28, 2026 (Business Wire)
Mar-16-26 07:05AM	NeoGenomics PanTracer LBx Receives Medicare Coverage, Expanding Access to Comprehensive Liquid Biopsy Profiling (Business Wire)
Feb-25-26 11:08PM	3 Reasons to Avoid NEO and 1 Stock to Buy Instead (StockStory)
07:05AM	NeoGenomics Launches RaDaR ST, Expanding Molecular Residual Disease Testing Across Multiple Solid Tumor Types (Business Wire)
Feb-24-26 12:33AM	5 Insightful Analyst Questions From NeoGenomics's Q4 Earnings Call (StockStory)
Feb-20-26 09:35AM	After Plunging 22.8% in 4 Weeks, Here's Why the Trend Might Reverse for NeoGenomics (NEO) (Zacks)
Feb-18-26 03:55PM	Why NeoGenomics (NEO) Shares Are Falling Today (StockStory) -10.31%
07:05AM	Loading…
07:05AM	NeoGenomics to Participate in Upcoming Investor Conferences (Business Wire)
12:32AM	NEO Q4 Deep Dive: Product Mix Shift and Guidance Weigh on Outlook (StockStory)
Feb-17-26 04:02PM	NeoGenomics Inc (NEO) Q4 2025 Earnings Call Highlights: Record Revenue and Strategic Growth ... (GuruFocus.com)
10:42AM	NeoGenomics Q4 Earnings Call Highlights (MarketBeat)
08:15AM	NeoGenomics (NEO) Q4 Earnings and Revenues Surpass Estimates (Zacks)
07:35AM	NeoGenomics's (NASDAQ:NEO) Q4 CY2025 Sales Beat Estimates (StockStory)
07:26AM	NeoGenomics: Q4 Earnings Snapshot (Associated Press Finance)
07:05AM	NeoGenomics Reports Fourth Quarter and Full Year 2025 Results (Business Wire)
Feb-16-26 08:59AM	NeoGenomics Announces Launch of New Cancer Assay PanTracer Pro (Zacks)
Feb-15-26 10:03PM	NeoGenomics (NEO) Q4 Earnings Report Preview: What To Look For (StockStory)
Feb-12-26 07:05AM	NeoGenomics Introduces PanTracer Pro to Support Timely, Informed Solid Tumor Therapy Selection (Business Wire)
Jan-27-26 07:05AM	NeoGenomics to Report Fourth Quarter and Full Year 2025 Financial Results on February 17, 2026 (Business Wire)
Jan-12-26 07:05AM	NeoGenomics Announces Preliminary Fourth Quarter and Full-Year 2025 Revenue (Business Wire) -5.09%
Jan-05-26 07:05AM	NeoGenomics to Participate in the 44th Annual J.P. Morgan Healthcare Conference (Business Wire)
Dec-30-25 07:05AM	NeoGenomics Appoints Diagnostics and Lab Services Industry Veteran John P. Jack Kenny to its Board of Directors (Business Wire)
11:33PM	Loading…
Dec-16-25 11:33PM	3 Stocks Under $50 We Steer Clear Of (StockStory)
Dec-15-25 07:05AM	NeoGenomics Announces that Natera Has Voluntarily Withdrawn its Appeal in Ongoing RaDaR Patent Litigation (Business Wire)
Dec-10-25 07:05AM	NeoGenomics to Present New ctDNA Research at SABCS 2025 (Business Wire)
Dec-08-25 08:05AM	NeoGenomics to Present Real-World Study on Comprehensive Genomic Profiling in Myeloid Malignancies at ASH 2025 (Business Wire)
Dec-05-25 11:19AM	Testing & Diagnostics Services Stocks Q3 Recap: Benchmarking NeoGenomics (NASDAQ:NEO) (StockStory)
Nov-21-25 06:36PM	NeoGenomics, Fortrea, and Acadia Healthcare Shares Skyrocket, What You Need To Know (StockStory) +8.30%
Nov-06-25 07:05AM	NeoGenomics to Participate in Upcoming Investor Conferences (Business Wire)
Nov-04-25 12:38AM	The Top 5 Analyst Questions From NeoGenomics's Q3 Earnings Call (StockStory)
Nov-03-25 11:01PM	NeoGenomics (NEO): Buy, Sell, or Hold Post Q3 Earnings? (StockStory)
Oct-30-25 12:51PM	NeoGenomics to Present RaDaR ST Bridging Study at ISLB 2025, Demonstrating Reliable MRD Detection Across Solid Tumors (Business Wire) -5.74%
Oct-29-25 01:33AM	NEO Q3 Deep Dive: Clinical Volume Gains and New Product Launches Shape Outlook (StockStory)
Oct-28-25 12:11PM	Why NeoGenomics (NEO) Stock Is Trading Up Today (StockStory)
08:15AM	NeoGenomics (NEO) Surpasses Q3 Earnings and Revenue Estimates (Zacks)
07:49AM	NeoGenomics's (NASDAQ:NEO) Q3 Sales Top Estimates, Stock Soars (StockStory)
07:15AM	NeoGenomics: Q3 Earnings Snapshot (Associated Press Finance)
07:05AM	NeoGenomics Reports Third Quarter 2025 Results (Business Wire)
Oct-26-25 11:15PM	NeoGenomics (NEO) Reports Earnings Tomorrow: What To Expect (StockStory)
Oct-24-25 12:39AM	3 Healthcare Stocks Walking a Fine Line (StockStory)
Oct-23-25 07:10AM	Armata Pharmaceuticals (ARMP) Surges 103.2%: Is This an Indication of Further Gains? (Zacks)
Oct-16-25 03:54AM	NeoGenomics (NEO) Moves 6.3% Higher: Will This Strength Last? (Zacks)
Oct-14-25 07:05AM	NeoGenomics to Highlight RaDaR ST MRD Assay at ESMO Congress 2025 (Business Wire)
Oct-07-25 07:05AM	NeoGenomics to Report Third Quarter 2025 Financial Results on October 28, 2025 (Business Wire)
Sep-24-25 09:10AM	Here's Alger Weatherbie Specialized Growth Fund's Comment on NeoGenomics (NEO) (Insider Monkey)
Sep-10-25 04:35PM	Why NeoGenomics (NEO) Shares Are Falling Today (StockStory) +11.50%
Sep-04-25 09:36AM	Brown Advisory Small-Cap Growth Strategy Sold Neogenomics (NEO) Following the News of CEO Departure (Insider Monkey)
Sep-02-25 09:30AM	Breakthrough Cancer Therapies Fuel Regulatory Momentum as Global Market Expands (PR Newswire)
Aug-29-25 05:05PM	Health Care Roundup: Market Talk (The Wall Street Journal) +21.78%
01:46PM	Why Is NeoGenomics (NEO) Stock Soaring Today (StockStory)
01:04PM	NeoGenomics Gains 'Unexpected' Win As Court Rejects Natera Claims (Benzinga)
Aug-26-25 08:42AM	Tempus' Key Acquisitions Strengthen Its AI Healthcare Leadership (Zacks)
Aug-20-25 11:36PM	Testing & Diagnostics Services Stocks Q2 Teardown: NeoGenomics (NASDAQ:NEO) Vs The Rest (StockStory)
Aug-13-25 05:51PM	NeoGenomics, Progyny, Repligen, Revvity, and Waters Corporation Shares Are Soaring, What You Need To Know (StockStory)
Aug-12-25 12:56AM	NEO Q2 Deep Dive: Guidance Reset Amid Pharma Weakness, Delayed Product Launches (StockStory)
12:39AM	NeoGenomics's Q2 Earnings Call: Our Top 5 Analyst Questions (StockStory)
Aug-07-25 03:36PM	Why NeoGenomics (NEO) Stock Is Trading Up Today (StockStory)
Jul-30-25 09:55AM	Down 29.2% in 4 Weeks, Here's Why NeoGenomics (NEO) Looks Ripe for a Turnaround (Zacks)
09:40AM	Peloton upgraded, Booking downgraded: Wall Street's top analyst calls (The Fly)
07:05AM	NeoGenomics Launches PanTracer LBx, Expanding Access to Comprehensive Genomic Profiling with Liquid Biopsy (Business Wire)
05:07AM	Fort Myers-based NeoGenomics sees stock plunge after reporting mixed results for Q2 (The News-Press)
Jul-29-25 02:26PM	Why NeoGenomics (NEO) Shares Are Falling Today (StockStory) -18.73%
08:15AM	NeoGenomics (NEO) Meets Q2 Earnings Estimates (Zacks)
07:57AM	NeoGenomics (NASDAQ:NEO) Misses Q2 Sales Targets, Stock Drops 15.8% (StockStory)
07:14AM	NeoGenomics: Q2 Earnings Snapshot (Associated Press Finance)
07:05AM	NeoGenomics Reports Second Quarter 2025 Results (Business Wire)
Jul-27-25 11:08PM	NeoGenomics (NEO) Reports Q2: Everything You Need To Know Ahead Of Earnings (StockStory)
Jul-24-25 10:00AM	Analysts Estimate Amicus Therapeutics (FOLD) to Report a Decline in Earnings: What to Look Out for (Zacks)
Jul-14-25 11:31PM	Q1 Earnings Highlights: NeoGenomics (NASDAQ:NEO) Vs The Rest Of The Testing & Diagnostics Services Stocks (StockStory)
Jul-11-25 03:30PM	NeoGenomics, RadNet, Pediatrix Medical Group, Penumbra, and Neogen Shares Plummet, What You Need To Know (StockStory)
Jul-02-25 08:49AM	Here's Why NeoGenomics (NEO) Sold Off in Q1 (Insider Monkey)
Jul-01-25 07:05AM	NeoGenomics to Report Second Quarter 2025 Financial Results on July 29, 2025 (Business Wire)
Jun-30-25 07:05AM	NeoGenomics Announces PanTracer Tissue and PanTracer Tissue + HRD Now Available to Support More Informed and Timely Cancer Care (Business Wire)
Jun-24-25 04:27PM	3 Hot Trades for Insiders, But Are They Good Buys for Investors? (MarketBeat)
02:19PM	5 Insightful Analyst Questions From NeoGenomics's Q1 Earnings Call (StockStory)
07:05AM	NeoGenomics Appoints Dr. Marjorie Green to Board of Directors (Business Wire)
May-28-25 07:10AM	NeoGenomics Debuts PanTracer Family of Genomic Profiling Tests at ASCO 2025 (Business Wire)
May-23-25 10:09AM	NeoGenomics introduces c-MET companion diagnostic for NSCLC (Medical Device Network)
May-22-25 07:10AM	NeoGenomics Launches c-MET CDx Assay to Guide Treatment Decisions for Advanced Non-Small Cell Lung Cancer (Business Wire)
May-20-25 07:05AM	NeoGenomics to Participate in Upcoming June Investor Conferences (Business Wire)
12:40AM	3 Healthcare Stocks with Mounting Challenges (StockStory)
May-06-25 09:30AM	It's Not Too Late to Jump on These Under-the-Radar Momentum Plays (MarketBeat)
May-05-25 12:34AM	3 Small-Cap Stocks Walking a Fine Line (StockStory)
May-01-25 11:55AM	NeoGenomics price target lowered to $10 from $17 at Morgan Stanley (TipRanks) +13.53%
07:05AM	NeoGenomics Pays Off 1.25% Convertible Senior Notes (Business Wire)
Apr-30-25 09:00AM	NeoGenomics Q1 Earnings: The Stock Price Drop Is A Gift (Rating Upgrade) (Seeking Alpha)
03:09AM	NeoGenomics Inc (NEO) Q1 2025 Earnings Call Highlights: Strong Revenue Growth and Strategic ... (GuruFocus.com)
Apr-29-25 03:49PM	Why NeoGenomics (NEO) Stock Is Nosediving (StockStory) -34.00%
12:18PM	NeoGenomics, Inc (NEO) Q1 2025 Earnings Call Transcript (Seeking Alpha)
08:40AM	NeoGenomics (NEO) Reports Break-Even Earnings for Q1 (Zacks)
08:00AM	NeoGenomics and Ultima Genomics collaborate to expand clinical test offerings in Oncology using the UG 100 sequencing platform (PR Newswire)
07:56AM	NeoGenomics (NASDAQ:NEO) Misses Q1 Sales Targets, Stock Drops (StockStory)

NeoGenomics, Inc. is a clinical laboratory company, which engages in cancer genetics diagnostic testing and pharma services. The company was founded by Michael T. Dent on October 29, 1998 and is headquartered in Fort Myers, FL.

CEO & DirectorMr. Anthony P. Zook

President & COOMr. Warren Stone

Chief Digital & Information OfficerMs. Elizabeth A. Floegel

Executive VP of Business DevelopmentMs. Alicia C. Olivo

Chief People & Culture OfficerMr. Gary Passman

Insider Trading	Relationship	Date	Transaction	Cost	#Shares	Value ($)	#Shares Total	SEC Form 4
TETRAULT LYNN A.	Director	Jun 09 '26	Sale	11.29	5,307	59,916	91,422	Jun 11 04:10 PM
LYNN TETRAULT	Director	Jun 09 '26	Proposed Sale	10.95	5,307	58,112		Jun 09 04:22 PM
Kenny John P.	Director	Jun 01 '26	Option Exercise	0.00	5,893	0	5,893	Jun 03 07:48 PM
Williams Felicia	Director	Jun 01 '26	Option Exercise	0.00	23,077	0	30,237	Jun 03 07:47 PM
TETRAULT LYNN A.	Director	Jun 01 '26	Option Exercise	0.00	23,077	0	96,729	Jun 03 07:47 PM
Perez David Brian	Director	Jun 01 '26	Option Exercise	0.00	23,077	0	56,967	Jun 03 07:46 PM
Kelly Michael Aaron	Director	Jun 01 '26	Option Exercise	0.00	23,077	0	67,086	Jun 03 07:46 PM
KANOVSKY STEPHEN M	Director	Jun 01 '26	Option Exercise	0.00	23,077	0	75,421	Jun 03 07:46 PM
Gunn Neil	Director	Jun 01 '26	Option Exercise	0.00	23,077	0	51,177	Jun 03 07:45 PM
Green Marjorie C	Director	Jun 01 '26	Option Exercise	0.00	22,964	0	22,964	Jun 03 07:45 PM
Olivo Alicia C	EVP, GC & Business Development	May 11 '26	Option Exercise	0.00	3,944	0	96,126	May 13 04:19 PM
Stone Warren	Pres & Chief Operating Officer	May 11 '26	Option Exercise	0.00	5,830	0	167,815	May 13 04:18 PM
Aunan Greg D	Chief Accounting Officer	May 02 '26	Option Exercise	0.00	5,372	0	26,462	May 05 04:27 PM
Stone Warren	Pres & Chief Operating Officer	May 02 '26	Option Exercise	0.00	5,969	0	164,334	May 05 04:26 PM
Stone Warren	Pres & Chief Operating Officer	Apr 01 '26	Option Exercise	0.00	17,562	0	165,276	Apr 03 04:39 PM
Zook Anthony P.	Chief Executive Officer	Apr 01 '26	Option Exercise	0.00	140,498	0	178,564	Apr 03 04:38 PM
Stone Warren	Pres & Chief Operating Officer	Feb 23 '26	Option Exercise	0.00	8,443	0	151,037	Feb 24 04:15 PM
Stone Warren	Pres & Chief Operating Officer	Feb 21 '26	Option Exercise	0.00	28,105	0	149,736	Feb 24 04:15 PM
Sherman Jeffrey Scott	Chief Financial Officer	Feb 23 '26	Option Exercise	0.00	15,535	0	223,792	Feb 24 04:15 PM
Sherman Jeffrey Scott	Chief Financial Officer	Feb 21 '26	Option Exercise	0.00	42,158	0	218,986	Feb 24 04:15 PM
Olivo Alicia C	EVP, GC & Business Development	Feb 23 '26	Option Exercise	0.00	8,443	0	96,547	Feb 24 04:14 PM
Olivo Alicia C	EVP, GC & Business Development	Feb 21 '26	Option Exercise	0.00	21,079	0	96,399	Feb 24 04:14 PM
Aunan Greg D	Chief Accounting Officer	Feb 21 '26	Option Exercise	0.00	6,323	0	23,902	Feb 24 04:14 PM
Stone Warren	Pres & Chief Operating Officer	Jan 20 '26	Sale	12.50	22,128	276,682	121,631	Jan 21 09:01 PM
WARREN STONE	Officer	Jan 20 '26	Proposed Sale	12.79	22,128	283,017		Jan 20 04:30 PM
Stone Warren	Pres & Chief Operating Officer	Jan 13 '26	Option Exercise	0.00	59,382	0	158,886	Jan 15 04:22 PM
Olivo Alicia C	EVP, GC & Business Development	Jan 13 '26	Option Exercise	0.00	59,382	0	90,465	Jan 15 04:22 PM
Olivo Alicia C	EVP, GC & Business Development	Nov 25 '25	Option Exercise	10.05	8,977	90,219	51,999	Nov 28 04:18 PM
Olivo Alicia C	EVP, GC & Business Development	Nov 25 '25	Sale	12.00	20,916	250,992	31,083	Nov 28 04:18 PM
ALICIA OLIVO	Officer	Nov 25 '25	Proposed Sale	11.61	11,939	138,612		Nov 25 04:27 PM
ALICIA OLIVO	Officer	Oct 16 '25	Proposed Sale	9.97	4,918	49,032		Oct 16 04:22 PM
Sherman Jeffrey Scott	Chief Financial Officer	Aug 06 '25	Buy	5.62	20,000	112,322	188,332	Aug 06 04:07 PM
Zook Anthony P.	Chief Executive Officer	Aug 06 '25	Buy	5.58	17,900	99,954	38,066	Aug 06 04:07 PM

open in yahoo | open in reuters | open in marketwatch | open in google | open in EDGAR

NEO

Neogenomics Inc

Upgrade your Finviz experience